Results 71 to 80 of about 225,386 (188)
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
, 2017 Graves' ophthalmopathy is defined as autoimmune inflammation of extraocular muscles and orbital fat or connective tissue, usually in patients with Graves' disease.
Wiersinga, Wilmar M.
core +1 more source
, 2011 Purpose: Graves' ophthalmopathy (GO) involves autoimmune process resulting in proptosis, congestion, oedema and diplopia. Werner's NOSPECS classification and clinical activity score (CAS) of GO cannot objectively describe the inflammatory status. Digital
施翔蓉;李弘元;蕭永廉;張天鈞 +1 more
core +1 more source
HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients
, 1990 Fifty-seven patients with severe Graves' ophthalmopathy were treated with corticosteroids. Therapeutic outcome was assessed according to predetermined criteria as response (n = 37) or non-response (n = 20) to therapy.
D'Amaro, J. +8 more
core +1 more source
Bilateral severe Graves’ ophthalmopathy exacerbated by Ethiopian folk medicine: A case report
Indian Journal of Ophthalmology. Case ReportsThis case report discusses a 48-year-old Ethiopian patient with Graves’ ophthalmopathy who turned to an Ethiopian folk remedy involving medicinal smoke, leading to the exacerbation of Graves’ ophthalmopathy.
Konstantin Yaakov Gushansky +2 more
doaj +1 more source
Euthyroid Graves' Ophthalmopathy With Negative Autoantibodies
, 2005 Graves' disease is an autoimmune-based hyperthyroidism in which a number of different antibodies directed against thyroid tissue plays a role. Graves' ophthalmopathy is thought to be a consequence of this autoimmune basis and occurs in some ...
Çakır, Mehtap
core
, 1984 In patients with Graves\u27 ophthalmopathy muscle enlargement is due to the deposition of mucopolysccharides, fibrosis, mononuclear cell infiltration, and edema. The exact etiology of tills change is not known, but is thought to be on an autoimmune basis.
Robert A. Egan
core
Clinical Ophthalmology, 2014 Jack R Wall,1 Hooshang Lahooti,1 Ilhem El Kochairi,1 Simon D Lytton,2 Bernard Champion1 1Department of Medicine, the University of Sydney, Penrith, NSW, Australia; 2SeraDiaLogistics, Munich, Germany Abstract: Although ophthalmopathy is mainly ...
Wall JR +4 more
doaj
Medical management of Graves' ophthalmopathy
, 1995 In most patients with Graves' hyperthyroidism the eye signs are self-limiting and mostly subclinical. However, about one-third of the patients have clinically relevant ophthalmopathy, which can be disabling and disfiguring.
Prummel, M. F., Wiersinga, W. M.
core +1 more source
Inactive Graves' ophthalmopathy and self-esteem [PDF]
, 2008 PURPOSE: To assess the self-esteem of Graves' ophthalmopathy patients in the inactive phase. METHODS: Thirty euthyroid patients were evaluated in the inactive phase of disease with age ranging from 26 to 65 years, average of 43 ± 11,0 years, called study
Magalhães, Carlos Henrique de Toledo [UNIFESP] +5 more
core +1 more source